Quick Answer
IDEAYA Biosciences, Inc. reported Total Assets of $1.11 billion for the year ending 2025.
- IDEAYA Biosciences, Inc. showed a decrease of -1.3% in Total Assets from 2024 to 2025.
- This data is from IDEAYA Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2019: $133.36 million | Q3 2019: $122.33 million | Q1 2020: $101.79 million | Q2 2020: $184.51 million | Q3 2020: $301.38 million | Q1 2021: $326.10 million | Q2 2021: $328.40 million | Q3 2021: $399.44 million | Q1 2022: $358.87 million | Q2 2022: $338.01 million | Q3 2022: $410.91 million | Q1 2023: $364.75 million | Q2 2023: $527.56 million | Q3 2023: $532.94 million | Q1 2024: $961.53 million | Q2 2024: $973.66 million | Q3 2024: $1.24 billion | Q1 2025: $1.10 billion | Q2 2025: $1.04 billion | Q3 2025: $1.19 billion.
- Over the full 8 years of available data (2018 to 2025), IDEAYA Biosciences, Inc.'s Total Assets has grown by 1,049.1%.
- Historical annual values: Fiscal year 2025: $1.11 billion | Fiscal year 2024: $1.12 billion | Fiscal year 2023: $649.32 million | Fiscal year 2022: $387.97 million | Fiscal year 2021: $381.35 million | Fiscal year 2020: $298.27 million | Fiscal year 2019: $113.00 million | Fiscal year 2018: $96.54 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: